title: Human lipodystrophies: genetic and acquired diseases of adipose tissue.
abstract: Human lipodystrophies represent a heterogeneous group of diseases characterized by generalized or partial fat loss, with fat hypertrophy in other depots when partial. Insulin resistance, dyslipidemia and diabetes are generally associated, leading to early complications. Genetic forms are uncommon: recessive generalized congenital lipodystrophies result in most cases from mutations in the genes encoding seipin or the 1-acyl-glycerol-3-phosphate-acyltransferase 2(AGPAT2). Dominant partial familial lipodystrophies result from mutations in genes encoding the nuclear protein lamin A/C or the adipose transcription factor PPARgamma. Importantly, lamin A/Cmutations are also responsible for metabolic laminopathies, resembling the metabolic syndrome and progeria, a syndrome of premature aging. A number of lipodystrophic patients remain undiagnosed at the genetic level. Acquired lipodystrophy can be generalized, resembling congenital forms, or partial, as the Barraquer-Simons syndrome, with loss of fat in the upper part of the body contrasting with accumulation in the lower part. Although their etiology is generally unknown, they could be associated with signs of autoimmunity. The most common forms of lipodystrophies are iatrogenic. In human immunodeficiency virus-infected patients, some first-generation antiretroviral drugs were strongly related with peripheral lipoatrophy and metabolic alterations. Partial lipodystrophy also characterize patients with endogenous or exogenous long-term corticoid excess. Treatment of fat redistribution can sometimes benefit from plastic surgery. Lipid and glucose alterations are difficult to control leading to early occurrence of diabetic, cardiovascular and hepatic complications.
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Capeau
authors.forename: Jocelyne
authors.initials: J
authors.lastname: Magré
authors.forename: Martine
authors.initials: M
authors.lastname: Caron-Debarle
authors.forename: Claire
authors.initials: C
authors.lastname: Lagathu
authors.forename: Bénédicte
authors.initials: B
authors.lastname: Antoine
authors.forename: Vé Ronique
authors.initials: VR
authors.lastname: Béréziat
authors.forename: Olivier
authors.initials: O
authors.lastname: Lascols
authors.forename: Jean-Philippe
authors.initials: JP
authors.lastname: Bastard
authors.forename: Corinne
authors.initials: C
authors.lastname: Vigouroux
mesh_terms: D051103:1-Acylglycerol-3-Phosphate O-Acyltransferase / Q000235:genetics; D000273:Adipose Tissue / Q000473:pathology* / Q000503:physiopathology*; D006801:Humans; D034904:Lamin Type A / Q000235:genetics; D008060:Lipodystrophy / Q000235:genetics / Q000473:pathology / Q000503:physiopathology; D047495:PPAR gamma / Q000235:genetics
chemical_list: C494847:LMNA protein, human; D034904:Lamin Type A; D047495:PPAR gamma; D051103:1-Acylglycerol-3-Phosphate O-Acyltransferase